SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?


To: Biotech Jim who wrote (2823)11/5/2009 7:09:33 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 3158
 
>> just call me chicken? <<

I'll continue with "smart", if you don't mind.

:-)

Yeah, Merck said "no interest" in 2C agonists in their Munch white paper a couple of years ago. At about the same time, I predicted that expanded phase III trials would reveal a little valve pathology.

I think I was wrong, from what I've seen. Data speaks. Sure wish that it was my filter to lief's words/mouth.

Best! Rick